Literature DB >> 9142461

Antifungal and immunoadjuvant properties of fluconazole in mice immunosuppressed with morphine.

P Di Francesco1, R Gaziano, I A Casalinuovo, A T Palamara, C Favalli, E Garaci.   

Abstract

We investigated the efficacy of fluconazole on experimental disseminated candidiasis in mice immunocompromised by chronic morphine treatment. CD1 mice were severely immunosuppressed by repeated morphine administrations, i.e., subcutaneous (s.c.) injections of 75 mg/kg/day, 3 days before and 5 days after a systemic Candida albicans infection induced by intravenous administration of 1 x 10(6) fungal cells/mouse. Fluconazole (2.5 mg/kg, s.c., at 6, 24 and 48 h postinfection) was very effective in prolonging survival time of morphine-treated mice. Fluconazole treatment also promotes a recovery of killing activity of polymorphonuclear leukocyte cells suppressed by morphine administrations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142461     DOI: 10.1159/000239561

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

Review 1.  Pain management in the critically ill child.

Authors:  M Yaster; D G Nichols
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 1.967

Review 2.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

Review 3.  Opioids and infections in the intensive care unit should clinicians and patients be concerned?

Authors:  Craig R Weinert; Shravan Kethireddy; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-05       Impact factor: 4.147

4.  Effect of fluconazole on phagocytic response of polymorphonuclear leukocytes in a rat model of acute sepsis.

Authors:  Haseeb Ahmad Khan
Journal:  Mediators Inflamm       Date:  2005-02-24       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.